The suitability of freeze-dried plasmas from patients on oral anticoagulants to serve as reference material in the calibration of thromboplastins used in the control of oral anticoagulant treatment was assessed in two centres. One pooled normal plasma and four pooled plasmas from patients at different levels of anticoagulation were collected into HEPES-citrate containing Trasylol. The plasmas, in 1 ml volumes, were freeze dried in siliconized ampoules under the optimal conditions used for biological standards. Small aliquots of the same plasmas were stored at -70°C.
The standardization of the one-stage prothrombin time has been extensively studied and frequently reviewed (Biggs, 1965 (Biggs, , 1969 BiggsandDenson, 1966; Biggs and Denson, 1967a, b; van Horn, 1968; Denson, 1969; Miale andLaFond, 1969; Loeligerand Hemker, 1970; Loeliger, Meuwisse-Braun, Buiterdijk, Veltkamp, and Hemker, 1970; Poller, 1970a and b; Zucker, Cathey, and West, 1970; Poller, Thomson, and Alderson, 1971; Loeliger, 1972; Miale and Kent, 1973) . A number of different schemes for defining the therapeutic range and for standardizing the prothrombin time test are used in different countries. All these schemes are based on the use of one of the two types of reference materials, thromboplastins (Denson, 1966 (Denson, , 1967 Denson, 1970 Denson, , 1973 Poller, 1970b Poller, , 1971 Biggs and Bangham, 1971) or plasma (Miale and LaFond, 1969; Miale and Kent, 1972 ; (Bangham, Biggs, Brozovid, and Denson, 1973) .
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The suitability of thromboplastins to serve as longterm standards has been studied and documented (Denson, 1966 (Denson, , 1967 Poller, 1970b Poller, , 1971 Bangham et al, 1970 Bangham et al, , 1973 Biggs and Bangham, 1971) . A similar but much larger international collaborative study to investigate the use of reference plasmas is being organized. Two types of reference plasmas will be studied: first freeze-dried plasmas prepared from blood ofpatients on oral anticoagulants and secondly freeze-dried artificially prepared abnormal plasmas designed to mimic the situation in patients on oral anticoagulants. As a preliminary to this international trial we have studied the suitability of freeze-dried plasma collected from patients to serve as reference material and the results are reported here. Materials PLASMAS Five plasmas were studied, one normal and four plasmas collected from patients on oral anticoagulants. (table I) . The levels of factors VII, IX, and X and prothrombin were estimated by both laboratories in frozen samples and in freeze-dried samples stored at -20°C and + 37°C for two months, using the same freezedried reference plasma.
The behaviour of factor VII in reconstituted freezedried plasma was followed for 24 hours in one laboratory. Factor VII levels were measured immediately after reconstitution and after five, 10, 30, and 60 minutes, as well as after six hours and 24 hours.
The tests with five thromboplastins were done manually, whereas the factor assays were carried out using Depex coagulometers. The levels of the four vitamin-K-dependent factors were measured in frozen plasma and in freezedried plasma stored at -20 and + 37°C for two months, as shown in tables IV, V, VI, and VII. All four factors showed slight decrease in activity in samples stored at 37°C; this fall was most pronounced for factor IX. The two laboratories, each using different methods and substrate plasmas, were in good agreement except for factor VII, where laboratory 1 measured a slight fall in factor VII activity on storage, whereas laboratory 2 detected a slight rise.
The prothrombin times of plasmas stored at + 370C for two months were invariably slightly longer than those with plasma stored at -20°C, as shown in Thirdly, the preliminary accelerated degradation studies showed that the prothrombin times of freezedried plasma were invariably prolonged. This instability of freeze-dried plasma makes it unsuitable as a basis for standardization relying on clotting times.
The activation of factor VII, in Trasylol-treated, freeze-dried plasma follows the pattern already described (Brozovic and Gurd, 1972) for plasma with added soya bean trypsin inhibitor: the activation is most marked at 37-C, whereas little activation occurs at 4°C. This behaviour of factor VII makes the immediate use of freeze-dried plasma a prerogative for comparable and successful tests.
The limited degradation studies performed in this study are in good agreement with previously reported results on the stability of vitamin-Kdependent factors (Brozovic, Gurd, Robertson, and Bangham, 1971a, b) . It is of interest that factor IX appears to be the least stable of the four factors investigated. 
